Schering, GSK Reviewing Levitra Promotions After FDA Cites 15-Second TV Ad
This article was originally published in The Pink Sheet Daily
Executive Summary
Commercial for Levitra does not qualify as "reminder ad" because it includes effectiveness claims, agency says in an ad division letter. Acting Commissioner Crawford has expressed a desire to crack down on DTC ads in the erectile dysfunction category. Levitra is one of four products cited by the agency in letters posted over a two-day period.
You may also be interested in...
Late Night Viagra: Pfizer Supports Limiting Hours For Erectile Dysfunction DTC Ads
CEO McKinnell says he agrees with a proposal to limit broadcast commercials for erectile dysfunction agents to the hours of 10 p.m.-6 a.m. PhRMA says it cannot make product-specific recommendations in its forthcoming voluntary DTC guidelines but could urge that ads run at appropriate times to target a drug's indicated population.
Late Night Viagra: Pfizer Supports Limiting Hours For Erectile Dysfunction DTC Ads
CEO McKinnell says he agrees with a proposal to limit broadcast commercials for erectile dysfunction agents to the hours of 10 p.m.-6 a.m. PhRMA says it cannot make product-specific recommendations in its forthcoming voluntary DTC guidelines but could urge that ads run at appropriate times to target a drug's indicated population.
DTC Advertising "Tone-Down" Could Address FDA Concerns, Schering Says
Marketers will begin airing more balanced DTC ads as a result of increased scrutiny from FDA about the quality of some ads, Schering CFO Bertolini says. With Levitra, Schering now participates in what may be a high-risk market for DTC ads: erectile dysfunction disorder.